Lymph node-targeted immunotherapy mediates potent immunity resulting in regression of isolated or metastatic human papillomavirus-transformed tumors.
第一作者:
Kent A,Smith
第一单位:
Department of Research and Development, MannKind Corporation, Valencia, California, USA.
作者:
医学主题词
动物(Animals);癌症疫苗(Cancer Vaccines);细胞转化, 病毒(Cell Transformation, Viral);综合疗法(Combined Modality Therapy);细胞毒素类(Cytotoxins);女(雌)性(Female);人乳头瘤病毒16(Human papillomavirus 16);人类(Humans);免疫, 细胞(Immunity, Cellular);免疫疗法(Immunotherapy);淋巴结(Lymph Nodes);淋巴细胞, 肿瘤浸润(Lymphocytes, Tumor-Infiltrating);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);肿瘤转移(Neoplasm Metastasis);肿瘤(Neoplasms);乳头瘤病毒E7蛋白质类(Papillomavirus E7 Proteins);肿瘤负荷(Tumor Burden)
DOI
10.1158/1078-0432.CCR-09-0645
PMID
19789304
发布时间
2025-05-29
- 浏览20
Clinical cancer research
6167-76页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



